K+S Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St

March 16, 2025

K+S (ETR:SDF) Full Year 2024 Results

Key Financial Results

Revenue: €3.65b (down 5.7% from FY 2023).
Net loss: €66.8m (down by 132% from €209.9m profit in FY 2023).
€0.37 loss per share (down from €1.12 profit in FY 2023).

revenue-and-expenses-breakdown — XTRA:SDF Revenue and Expenses Breakdown March 16th 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

K+S Revenues Beat Expectations, EPS Falls Short

Revenue exceeded analyst estimates by 1.0%. Earnings per share (EPS) missed analyst estimates.

The primary driver behind last 12 months revenue was the Europe (Excluding Germany) segment contributing a total revenue of €1.52b (42% of total revenue). Notably, cost of sales worth €3.35b amounted to 92% of total revenue thereby underscoring the impact on earnings.Explore how SDF's revenue and expenses shape its earnings.

Looking ahead, revenue is forecast to stay flat during the next 3 years compared to a 3.9% growth forecast for the Chemicals industry in Germany.

Performance of the German Chemicals industry.

The company's shares are down 4.2% from a week ago.

Balance Sheet Analysis

Just as investors must consider earnings, it is also important to take into account the strength of a company's balance sheet. See our latest analysis on K+S' balance sheet health.

Valuation is complex, but we're here to simplify it.

Discover if K+S might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.